TissUse is a Berlin, Germany-based, biotechnology company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse’s Multi-Organ-Chips provide a new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.
TissUse’s Multi-Organ-Chips have been utilized in a large variety of applications including drug development, cosmetics, food and nutrition and consumer products since 2012.
Imprint: https://www.tissuse.com/en/imprint/
Privacy Policy: https://www.tissuse.com/en/privacy/
-
Branche
-
Biotechnologieforschung
-
Größe
-
11–50 Beschäftigte
-
Hauptsitz
-
Berlin
-
Art
-
Privatunternehmen
-
Gegründet
-
2010
-
Spezialgebiete
-
Biotechnology, Organ-on-a-Chip, Body-on-a-Chip, Tissue Engineering, Microfluidics, Assay Development, Patient-on-chip, Microphysiological system, Organoids, Contract Assay Development, Drug Development, Disease Modelling, Pharma, Toxicology, Pharmacokinetics, Pharmacodynamics, iPSC, Automation, AI und Cell Culture